Masco Boosts FY21 Adj. EPS Outlook; Declares Dividend - Quick Facts

While reporting financial results for the second quarter on Thursday, Masco Corp. (MAS) raised its adjusted earnings guidance for the full-year 2021 to a range of $3.65 to $3.75 per share from the previous expectation of $3.50 to $3.70 per share.

On average, 19 analysts polled by Thomson Reuters expect the company to report earnings of $3.63 per share for the year. Analysts' estimates typically exclude special items.

Masco's Board of Directors also declared a quarterly dividend of $0.235 per common share, payable on August 30, 2021, to shareholders of record on August 13, 2021.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Privately-held biotechnology company On Target Laboratories, Inc. announce that the U.S. Food and Drug Administration or FDA, has approved Cytalux (pafolacianine) for adult patients with ovarian cancer as an adjunct for intraoperative identification of malignant lesions. Cytalux is the first targeted fluorescent imaging agent that illuminates ovarian cancer intraoperatively. The Federal Trade Commission or FTC has ordered Walmart, Amazon, Kroger and certain other large wholesalers and suppliers to provide information to help it study causes of supply chain disruptions. The agency has launched an inquiry to find the reasons for empty shelves and exorbitant prices. Along with Walmart, Amazon.com, and Kroger, the order has been sent to C&S Wholesale Grocers, Associated.. Covid vaccine maker Moderna Inc.'s Chief Executive Stéphane Bancel has predicted that existing COVID-19 vaccines will be much less effective against Omicron than earlier strains, according to the Financial Times.
Follow RTT